JeremyDevinRubinsteinMD

PubMed

• Third-party virus specific T cells for the treatment of double stranded DNA viral reactivation and PTLD after solid organ transplant.
  Michael S Grimley, Adam S Nelson, Tom Leemhuis, Eleanor Cook, Daria Heyenbruch, Catherine M Bollard, Patrick J Hanley, Carolyn Lutzko, Giang Pham, Stella M Davies, Rub...> ;American Journal of Transplantation. 2024 Apr 19
• Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation.
  Abby Green, Jeremy D Rubinstein, Michael Grimley, Thomas Pfeiffer> ;Journal of the Pediatric Infectious Diseases Society. 2024 Feb 28
• 5 citations
  Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults.
  Jeremy Rubinstein, Keri Toner, Thomas Gross, Birte Wistinghausen> ;Best Practice & Research. Clinical Haematology. 2023 Mar 1
• 3 citations
  Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
  Zeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, Kavitha Srivatsa, Tamara P Miller, Holly J Edington, Mansi Dalal, Joanna Robles, James B Ford, Matthew J Ehrhardt,...> ;Cancer. 2023 Mar 1
• 1 citations
  Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of...
  Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski, Adam S Nelson, Ruby Khoury, Christopher E Dandoy, Stella M Davies, Christine L Phillips> ;Pediatric Blood & Cancer. 2023 May 1
• 2 citations
  The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy ...
  Jeremy D Rubinstein, Erin H Breese, M Christa Krupski, Maureen M O'Brien, Christopher E Dandoy, Ben Mizukawa, Ruby Khoury, Robin E Norris, Stella M Davies, Christine L...> ;Transplantation and Cellular Therapy. 2023 May 1
• 5 citations
  Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.
  Zeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, Mansi Dalal, James B Ford, Pallavi Pillai, Joanna M Robles, Sonika Reddy, Sarah McCormack, Matthew J Ehrhar...> ;British Journal of Haematology. 2023 Feb 1
• 8 citations
  Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic St...
  Thomas J Galletta, Adam Lane, Carolyn Lutzko, Thomas Leemhuis, Jose A Cancelas, Ruby Khoury, YunZu M Wang, Patrick J Hanley, Michael D Keller, Catherine M Bollard, Ste...> ;Transplantation and Cellular Therapy. 2023 May 1
• 2 citations
  Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy.
  Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert> ;Pediatric Blood & Cancer. 2023 Apr 1
• 10 citations
  Off the Shelf Third Party Virus Specific T-Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplant Recipients.
  Jeremy D. Rubinstein, Sonata Jodele, Daria Heyenbruch, Jamie Wilhelm, Shawn Thomas, Carolyn Lutzko, Xiang Zhu, Thomas Leemhuis, Jose A. Cancelas, Michael D. Keller, Ca...> ;Transplantation and Cellular Therapy. 2021 Nov 13
• 21 citations
  Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.
  Jeremy D. Rubinstein, Xiang Zhu, Thomas Leemhuis, Giang Pham, Lorraine Ray, Sana Emberesh, Sonata Jodele, Shawn Thomas, Jose A. Cancelas, Catherine M. Bollard, Patrick...> ;Blood Advances. 2021 Sep 14
• 3 citations
  Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective
  Jeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino, Robin E. Norris, Lynn Lee, Benjamin Mizukawa, Maureen M. O'Brien, Christine L Philli...> ;Pediatric Blood & Cancer. 2021 May 21
• 1 citations
  Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis.
  Myesa Emberesh, Jeremy D. Rubinstein, Jennifer Young, Stefanie W. Benoit, Christopher E. Dandoy, Brian Weiss> ;Pediatric Blood & Cancer. 2021 Mar 1
• 38 citations
  Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.
  Adam S. Nelson, Daria Heyenbruch, Jeremy D. Rubinstein, Anthony Sabulski, Sonata Jodele, Shawn Thomas, Carolyn Lutzko, Xiang Zhu, Thomas Leemhuis, Jose A. Cancelas, Mi...> ;Blood Advances. 2020 Nov 24
• 30 citations
  Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia.
  Jeremy D. Rubinstein, Christa Krupski, Adam S. Nelson, Maureen M. O'Brien, Stella M. Davies, Christine L Phillips> ;Biology of Blood and Marrow Transplantation. 2020 Nov 1
• 4 citations
  Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.
  Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael Grim...> ;Blood Advances. 2020 Jul 28
• 6 citations
  Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes.
  Nathan Luebbering, Sheyar Abdullah, Dana T. Lounder, Adam Lane, Nikhil Dole, Jeremy D. Rubinstein, Martin Hewison, Nicholas J. Gloude, Sonata Jodele, Kitty M R Perente...> ;Haematologica. 2020 Apr 2
• 1 citations
  A case of submandibular desmoplastic small round cell tumor: Diagnostic and management approaches to an atypical presentation of a rare tumor
  Jeremy D. Rubinstein, Anita Gupta, Sara Szabo, Joseph G. Pressey> ;Pediatric Blood & Cancer. 2020 Apr 1
• 3 citations
  EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.
  Jeremy D. Rubinstein, Karen Burns, Michael J. Absalon, Carolyn Lutzko, Tom Leemhuis, Sharat Chandra, Patrick J. Hanley, Michael D. Keller, Stella M. Davies, Adam S. Ne...> ;Pediatric Blood & Cancer. 2020 Mar 1
• 11 citations
  Chimeric antigen receptor T‐cell therapy in patients with neurologic comorbidities
  Jeremy D. Rubinstein, Adam S. Nelson, Christa Krupski, William J. O'Brien, J. Michael Taylor, Tom C. Badgett, Michael Huang, Stella M. Davies, Christine L Phillips> ;Pediatric Blood & Cancer. 2020 Feb 4
• 12 citations
  Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease
  Stephanie Cizek, Javier El-Bietar, Jeremy D. Rubinstein, Christopher E. Dandoy, Gregory Wallace, Adam S. Nelson, Pooja Khandelwal, Kasiani C. Myers, Holly R. Hoefgen> ;Biology of Blood and Marrow Transplantation. 2019 Dec 1
• 3 citations
  Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma
  Donald J. Lucas, Jeremy D. Rubinstein, Ankush Gosain, Greg Tiao, Tim Head, J Nick Pratap, Regan F. Williams, Sara Helmig, James I. Geller, Max R. Langham, Angela D. Tr...> ;Pediatric Blood & Cancer. 2019 Jun 1
• 1 citations
  Expanding the pediatric oncology medical home: Successful utilization of a medical-legal partnership at a pediatric oncology referral center.
  Jeremy D. Rubinstein, Joseph G. Pressey, Melissa Klein> ;Pediatric Blood & Cancer. 2019 May 1
• 26 citations
  Calpain 2 Activation of P-TEFb Drives Megakaryocyte Morphogenesis and Is Disrupted by Leukemogenic GATA1 Mutation
  Kamaleldin E. Elagib, Jeremy D. Rubinstein, Lorrie L. Delehanty, Valerie S. Ngoh, Peter A. Greer, Shuran Li, Jae K. Lee, Zhe Li, Stuart H. Orkin, Ivailo S. Mihaylov, A...> ;Developmental Cell. 2013 Dec 23
• 6 citations
  Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.
  Jeremy D. Rubinstein, Kamaleldin E. Elagib, Adam N. Goldfarb> ;The Journal of Biological Chemistry. 2012 Jun 1
• Join now to see all